Central Precocious Puberty

Following Approval, Triptorelin 6-Month Injection Now Available to Treat Central Precocious Puberty

Following Approval, Triptorelin 6-Month Injection Now Available to Treat Central Precocious Puberty

By

Gonadotropin-releasing hormone (GnRH) agonist Triptodur treats central precocious puberty via intramuscular injection.

FDA: Triptorelin Slows Central Precocious Puberty

FDA: Triptorelin Slows Central Precocious Puberty

By

Data from a phase 3 clinical trial found that triptorelin achieved positive results in patients age 2 and older with central precocious puberty.

Precocious Puberty More Common in Girls Than Boys

Precocious Puberty More Common in Girls Than Boys

By

Ovarian cyst and McCune-Albright syndrome were most responsible for the increased risk of non-congenital adrenal hyperplasia gonadotropin-independent precocious puberty.

Longer-Term Histrelin Safe, Effective for Central Precocious Puberty

Longer-Term Histrelin Safe, Effective for Central Precocious Puberty

By

Long-term treatment with the histrelin implant safely and effectively sustained gonadotropin suppression and improved predicted adult height in central precocious puberty.

Sign Up for Free e-Newsletters

CME Focus